{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T04:27:34Z","timestamp":1680236854482},"reference-count":18,"publisher":"Informa UK Limited","issue":"8","funder":[{"name":"Merck & Co., Inc., Rahway, NJ, USA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2022,11,17]]},"DOI":"10.1080\/14737167.2022.2117162","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T07:47:27Z","timestamp":1664178447000},"page":"1215-1220","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Economic evaluation of doravirine\/tenofovir disoproxil fumarate\/lamivudine for HIV-1-infected adults in Russia: a cost-minimization and budget impact analysis"],"prefix":"10.1080","volume":"22","author":[{"given":"Elena","family":"Pyadushkina","sequence":"first","affiliation":[{"name":"Autonomous Nonprofit Organization \u201cNational Center for Health Technology Assessment\u201d, Moscow, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Derkach","sequence":"additional","affiliation":[{"name":"Autonomous Nonprofit Organization \u201cNational Center for Health Technology Assessment\u201d, Moscow, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Rozenberg","sequence":"additional","affiliation":[{"name":"Republican Clinical Hospital of Infectious Diseases, Saint Petersburg, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dzhumber","family":"Ugrekhelidze","sequence":"additional","affiliation":[{"name":"MSD Pharmaceuticals, Moscow, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena","family":"Lobodina","sequence":"additional","affiliation":[{"name":"MSD Pharmaceuticals, Moscow, Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Baxter","sequence":"additional","affiliation":[{"name":"MSD (UK) Limited, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Beyer","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc., Rahway, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"cit0001","unstructured":"World Health Organization. HIV\/AIDS. 2020 [cited 2020 Sept 16]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids"},{"key":"cit0002","unstructured":"Ministry of Health of the Russian Federation. Rubricator clinical guidelines. HIV infection in adults. 2017 [cited 2019 Oct 9]. Available from: http:\/\/cr.rosminzdrav.ru\/#!\/schema\/899"},{"key":"cit0003","unstructured":"World Health Organization. HIV\/AIDS surveillance in Europe 2019. 2019 [cited 2020 Sept 22]. Available from: https:\/\/www.euro.who.int\/en\/health-topics\/communicable-diseases\/hivaids\/publications\/2019\/hivaids-surveillance-in-europe-2019"},{"key":"cit0004","unstructured":"Federal Service for Supervision of Consumer Rights Protection and Human Well-Being. On the state of the sanitary and epidemiological well-being of the population of the Russian Federation in 2020. 2019 [cited 2021 Jul 11]. Available from: https:\/\/rospotrebnadzor.ru\/about\/info\/news\/page1.php?ELEMENT_ID=18266 \u2022 shows the epidemiology of HIV in the Russian Federation."},{"key":"cit0005","unstructured":"Federal Budget Institution of Science. HIV infection in the Russian Federation on December 31, 2020. 2018 [cited 2021 Mar 9]. Available from: http:\/\/www.hivrussia.info\/wp-content\/uploads\/2021\/03\/VICH-infektsiya-v-Rossijskoj-Federatsii-na-31.12.2020-pdf"},{"key":"cit0006","unstructured":"National Scientific Society of Infectious Diseases. Recommendations for the treatment and chemoprevention of HIV and associated diseases. 2019 [cited 2020 Oct 7]. Available from: http:\/\/www.hivrussia.info\/wp-content\/uploads\/2019\/12\/Rekomendatsii-po-lecheniyu-VICH-infektsii-i-svyazannyh-s-nej-zabolevanijhimioprofilaktike-zarazheniya-VICH.pdf"},{"key":"cit0007","unstructured":"Ministry of Health of the Russian Federation. Approving the state strategy to combat the spread of HIV in Russia through 2020 and beyond 2016. [cited 2020 Oct 7]. Available from: http:\/\/government.ru\/en\/docs\/24983\/"},{"key":"cit0008","unstructured":"Ministry of Health of the Russian Federation. Approval of the standard first-line ART for special cases of HIV infection 2018. Order No. 799n. 2018 Nov 20 [cited 2020 Oct 7]. Available from: https:\/\/itpcru.org\/2019\/02\/20\/novye-standarty-pervichnoj-mediko-sanitarnoj-pomoshhi-vzroslym-pri-bolezni-vyzvannoj-vich\/"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2018.09.001"},{"key":"cit0010","unstructured":"Government of the Russian Federation. About approval of Rules of forming of lists of medicines for medical application and the minimum range of the medicines necessary for delivery of health care, 2020. Order No. 871. 2014 Aug 28 [cited 2020 Sept 25]. Available from: https:\/\/cis-legislation.com\/document.fwx?rgn=69386 \u2022\u2022 discusses the Russian regulatory framework."},{"key":"cit0011","unstructured":"Center for Healthcare Quality Assessment and Control. Ministry of Health of the Russian Federation. 2020 [cited 2020 Sept 25]. Available from: https:\/\/rosmedex.ru\/en\/about-us\/ \u2022\u2022 discusses the Russian regulatory framework."},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.02.010"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2013.08.2291"},{"key":"cit0014","unstructured":"Register of Medicines of the Russian Federation. cited 2019 Oct 12. Available from: https:\/\/grls.rosminzdrav.ru"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy540"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000169"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(97)00049-8"},{"key":"cit0018","volume-title":"Guidelines for the use of antiretroviral agents in adults and adolescents with HIV","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2022.2117162","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T11:54:14Z","timestamp":1680177254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2022.2117162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,11,17]]}},"alternative-id":["10.1080\/14737167.2022.2117162"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2022.2117162","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}